Strong Q4 Performance

Astrana Health (NASDAQ:ASTH) reported Q4 results of $950.5 million in revenue, a 42.9 % year‑on‑year increase and a 2.3 % beat on analysts’ revenue estimates. The company’s revenue growth was the fastest among its peers, and EPS also exceeded expectations. Astrana’s fully delegated, payer‑agnostic care model and AI‑enabled technology platform are cited as providing strength and predictability in a dynamic operating environment. Despite the earnings beat, the stock is trading at $24.27, up only 19.4 % since the announcement.